Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Kathryn Jenner"'
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 19, Iss 1, Pp 1-12 (2024)
Abstract Background Gene therapy has the potential to offer people with haemophilia (PwH) a life free from bleeding and the burden posed by current treatment regimens. To date, gene therapy has only been available in clinical trial settings, to PwH w
Externí odkaz:
https://doaj.org/article/23f1847bcd964eaba46739f8af1ef885
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-9 (2022)
Abstract Background Gene therapy has the potential to change the life experience of people with haemophilia and family members. Few studies have sought to explore the impact of gene therapy on both individuals and families. The aim of this study was
Externí odkaz:
https://doaj.org/article/12e45b570ed64589b8d8caada9e17e75
Publikováno v:
Health Expectations, Vol 25, Iss 1, Pp 443-454 (2022)
Abstract Background People with haemophilia A and inhibitors (PwHi) suffer more orthopaedic complications, bleeding and pain than those without inhibitors. The advent of emicizumab as a prophylactic treatment has led to a reduction in bleed frequency
Externí odkaz:
https://doaj.org/article/26f2cbf740384fc5a5b270b96455b773
Publikováno v:
Haemophilia. 29:776-783
Publikováno v:
Haemophilia. 28:316-325
Despite therapeutic advances in bleeding disorder treatment, over the past 20 years women with bleeding disorders have reported delayed diagnosis, impaired quality of life, dismissive attitudes from health professionals and inappropriate care.To expl
Publikováno v:
Health Expectations, Vol 25, Iss 1, Pp 443-454 (2022)
Background People with haemophilia A and inhibitors (PwHi) suffer more orthopaedic complications, bleeding and pain than those without inhibitors. The advent of emicizumab as a prophylactic treatment has led to a reduction in bleed frequency and a si
Publikováno v:
Orphanet journal of rare diseases. 17(1)
Background Gene therapy has the potential to change the life experience of people with haemophilia and family members. Few studies have sought to explore the impact of gene therapy on both individuals and families. The aim of this study was to captur
Publikováno v:
Haemophilia : the official journal of the World Federation of HemophiliaREFERENCES. 27(5)
Introduction For many people with haemophilia (PwH) gene therapy offers a potential functional cure. However, some have stated that they do not wish to have gene therapy either now or in the future. Aim This sub-study, part of the larger Exigency pro
Publikováno v:
2009 Annual Conference & Exposition Proceedings.
Publikováno v:
Haemophilia : the official journal of the World Federation of HemophiliaREFERENCES. 27(1)
Introduction Gene therapy is used in life-limiting conditions of childhood. While not a current therapeutic option for children with haemophilia, it may be considered in the future especially for those where access to treatment is limited. Aim To ass